Predictive markers of immune mediated adverse events and of treatment response in patients treated with durvalumab monotherapy or in combination with tremelimumab (IOPREDI study)
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Predictive markers of immune mediated adverse events and of treatment response in patients treated with durvalumab monotherapy or in combination with tremelimumab (IOPREDI study) |
| Type de publication | Journal Article |
| Year of Publication | 2018 |
| Auteurs | Marabelle A., Ghiringhelli F., Ayyoub M., Tartour E., Adotevi O., Loriot Y., Lambotte O., Cupissol D., Damotte D., Adam J., Bonvalet M., B. Lazar P, Licour M., Chaput N. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 29 |
| Pagination | 10 |
| Date Published | DEC |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |